Applied Therapeutics, Inc. (APLT)
$0.10+0.00%Close
SELLRECOVERY · day 3
Key stats
- Market cap
- $14M
- Beta
- 2.08
- P/E (TTM)
- -0.37
- 1W
- +11.11%
- 1M
- +0.00%
- vs SPY 1W
- +11.25%
- vs SPY 1M
- -2.51%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-286.7%
REV YoY-
ROE-477.8%
EPS YoY-
ROA-117.3%
GROSS-892
OP-3986
NET-4032
[VALUATION]
P/E TTM-0.37
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B-26.72
P/FCF-
EV/EBITDA-0.14
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.96
ND/EBITDA-
BETA2.08
Company news
FAQ
- What is LOPJLB’s current signal on APLT?
- LOPJLB’s latest quantitative signal on Applied Therapeutics, Inc. (APLT) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is APLT in?
- Applied Therapeutics, Inc. (APLT) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Applied Therapeutics, Inc. (APLT) do?
- Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. The company's primary drug candidate, AT-007, has successfully concluded Phase 1/2 studies for galactosemia in healthy adult volunteers and is presently in a pediatric clinical study for the s…